Alexion Pharmaceuticals Shares Fall Following CFO Change
By Patrick Thomas
Shares of Alexion Pharmaceuticals Inc. (ALXN) were off about 5%
to $102.40 on Wednesday after the company named its next finance
The company said CFO Paul Clancy will be succeeded by Aradhana
Sarin, currently its chief strategy and business officer, later
this year. The transition will take place after the company reports
its third-quarter financial results, Alexion said. Ms. Sarin joined
the company in November 2017.
Mr. Clancy is expected to stay on as a senior adviser until
mid-2020 when his employment agreement expires, according to a
Tuesday securities filing.
Alexion shares are up about 5% this year, but down 15% over the
past 12 months.
Write to Patrick Thomas at email@example.com
(END) Dow Jones Newswires
September 18, 2019 11:40 ET (15:40 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.